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Abstract 13 
Cobalt-chromium (CoCr) particles in the nanometre size range and their concomitant release 14 
RI &R DQG &U LRQV LQWR WKH SDWLHQWV¶ FLUFXODWLRQ are produced by wear at the articulating 15 
surfaces of metal-on-metal (MoM) implants. This process is associated with inflammation, 16 
bone loss and implant loosening and led to the withdrawal from the market of the DePuy 17 
ASRTM MoM hip replacements in 2010. Ions released from CoCr particles derived from a 18 
resurfacing implant in vitro and their subsequent cellular up-take were measured by ICP-MS. 19 
Moreover, the ability of such metal debris and Co ions to induce both apoptosis was 20 
evaluated with both FACS and immunoblotting. qRT-PCR was used to assess the effects on 21 
the expression of lymphotoxin alpha (LTA), BCL2-associated athanogene (BAG1), nitric 22 
oxide synthase 2 inducible (NOS2), FBJ murine osteosarcoma viral oncogene homolog 23 
(FOS), growth arrest and DNA-damage-inducible alpha (GADD45A). ICP-MS showed that 24 
the wear debris released significant (p<0.05) amounts of Co and Cr ions into the culture 25 
medium, and significant (p<0.05) cellular uptake of both ions. There was also an increase 26 
(p<0.05) in apoptosis after 48h exposure to wear debris. Analysis of qRT-PCR results found 27 
significant up-regulation (p<0.05) particularly of NOS2 and BAG1 in Co pre-treated cells 28 
which were subsequently exposed to Co ions+debris. Metal debris was more effective as an 29 
inducer of apoptosis and gene expression when cells had been pre-treated with Co ions. This 30 
suggests that if a patient receives sequential bilateral CoCr implants, the second implant may 31 
be more likely to produce adverse effects than the first one.  32 
 33 
Keywords: CoCr wear debris, Co ions; metal-on-metal hip replacements; apoptosis; 34 
toxicology gene expression. 35 
 36 
Introduction 37 
 38 
Despite improvements in implant design and surgical techniques, periprosthetic osteolysis 39 
causing aseptic loosening of artificial joints is still a complication limiting clinical success of 40 
total joint arthroplasty as the treatment of joint diseases (1, 2). When a hip replacement fails 41 
revision surgery may need to be performed. This causes morbidity risk for the patient (3) and, 42 
as the peri-implant tissue has been sensitised, the replacement implant may have an increased 43 
chance of failing. Particulate wear debris generated from the implants can provoke biological 44 
tissue responses, including vascularized granulomatous tissue formation along the implant-to-45 
bone interface, inflammatory cell (macrophages, lymphocytes) influx, bone resorption, 46 
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osteolysis, and finally loss of prosthesis fixation (4). As part of the foreign body response to 47 
implants, macrophages are the cells that provide surveillance and coordinate the 48 
inflammatory cascade leading to wound healing and implant stability (2). The presence of 49 
wear debris in the peri-implant area leads to phagocytosis of particulate debris by 50 
macrophages and activation of these cells stimulates the release of a variety of mediators, 51 
such as free radicals and nitric oxide, as well as bone resorbing mediators such as interleukin-52 
1 (IL-1), tumour necrosis factor-Į 71)-Į SURVWDJODQGLQ ( 3*( DQG ,/-6 (1). 53 
Additionally, Metals debris and metal ions can activate the immune system by inducing a 54 
delayed type IV hypersensitivity reaction (5). The most common sensitizing orthopaedic 55 
metals are nickel, cobalt, and chromium (5, 6). It is thought that the stimulated T-cells 56 
generate pro-osteoclastogenetic factors that can alter bone homeostasis (7) and therefore 57 
contribute to osteolysis. The prevalence of metal sensitivity among the general population is 58 
approximately 10% to 15% and the prevalence of metal sensitivity among patients with well-59 
functioning and poorly functioning implants has been reported to be ~25% and 60%, 60 
respectively, as measured by dermal patch testing (5). The response of metal-specific 61 
lymphocytes has been linked to poor implant performance. Cell-mediated type-IV 62 
hypersensitivity reaction characterized by vasculitis with perivascular and intramural 63 
lymphocytic infiltration of the postcapillary venules, swelling of the vascular endothelium, 64 
recurrent localized bleeding, and necrosis has been reported following metal-on-metal hip 65 
replacements (8). 66 
 67 
During revision surgeries or postmortem examination, discoloured tissue is frequently 68 
observed around CoCr implants; some patients feel unexplained pain that may be associated 69 
with the tissue damage caused by MoM hip replacement wear (3). Elevated levels of Co and 70 
Cr ions occur in the peripheral blood and in the hip synovial fluid after CoCr alloy metal-on-71 
metal (MoM) hip replacement, and there is concern also about the toxicity and biological 72 
effects of such ions both locally and systemically (9, 10). The Medicines and Healthcare 73 
Products Regulatory Authority (MHRA) have suggested that combined whole blood Co and 74 
Cr levels of greater than 7ppb (7µg/l or 0.1µM) are associated with significant soft tissue 75 
reactions and failed hip implants.  76 
 77 
Co ions and nanoparticles are cytotoxic and induce apoptosis, and at higher concentrations, 78 
necrosis, with inflammatory responses (11). It has been demonstrated that macrophage 79 
mortality induced by metal ions depends on the type and concentration of metal ions as well 80 
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as the duration of the exposure (12). Cobalt corrodes faster than chromium under 81 
physiological conditions (13) and, opposite to Cr, Co ions tend to remain mobile, which is 82 
reflected in the higher levels measured in blood, allowing them to reach remote organs (14). 83 
Elevated Co concentrations in patients with MoM implants are a concern, since increased 84 
cobalt levels in blood have also been reported to be associated with neurological (hand 85 
tremor, incoordination, cognitive decline, depression, vertigo, hearing loss, and visual 86 
changes) (15, 16) cardiac (myocardiopathy) (17) and endocrine (16) symptoms.  87 
 88 
Over the past few years, a number of investigations have been carried out to study the effects 89 
of metal ions and particulate wear debris on the expression of an array of genes in vitro. 90 
+RZHYHUWRWKHDXWKRUV¶NQRZOHGJHWKHH[SUHVVLRQRIKXPDQWR[LFRORJ\UHODWHGJHQHVVXFK91 
as lymphotoxin alpha (LTA), BCL2-associated athanogene (BAG1), growth arrest and DNA-92 
damage-inducible alpha (GADD45A) and FBJ murine osteosarcoma viral oncogene homolog 93 
(FOS) has not been studied in the context of prosthetic wear debris.  Patients undergo chronic 94 
exposure to this wear debris so a time point of 120h was chosen in this study to investigate 95 
any longer term in vitro effects on gene expression in the cells. 96 
 97 
LTA, a member of the TNF family, is an inflammatory mediator that influences multiple 98 
processes such as activation, proliferation, differentiation, and death induction in many 99 
different cell types (18). BAG1 is a multifunctional protein able to delay cell death by a 100 
synergistic action with BCL2 (19). The family of growth arrest and DNA damage (GADD) 101 
proteins is composed of five regulatory molecules that function primarily to protect cells and 102 
ensure survival by inducing cell cycle arrest, DNA repair or promoting apoptosis (20). The 103 
FOS gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. FOS is a critical 104 
factor involved in osteoclast development and activation (21). Moreover, a pivotal role of 105 
FOS in nitric oxide synthase 2 (NOS2) expression in airway epithelial cells has been 106 
suggested (22). NOS2 is widely expressed in every type of tissue and cell after transcriptional 107 
induction following exposure to a vast array of immunologic and inflammatory stimuli (23). 108 
 109 
In this study, ions released from CoCr particles derived from a resurfacing implant as well as 110 
their subsequent cellular up-take were measured by inductively coupled plasma mass 111 
spectrometry (ICP-MS). Moreover, the ability of the metal debris and cobalt (Co) ions to 112 
induce both apoptosis and general toxicology-related gene expression of human monocyte-113 
like U937 cells was examined. In some experiments the cells were pre-treated with Co ions 114 
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prior to exposure to CoCr particles, in order to simulate the in vivo situation where a patient 115 
may receive a second MoM implant either a bilateral or a revision procedure. Co ion 116 
concentrations used in the present experiments were 0.1µM, reflecting the upper blood level 117 
threshold recommended b\ 0+5$ IRU SDWLHQW VDIHW\ 7R WKH DXWKRUV¶ NQRZOHGJH SULPLQJ118 
cells with metal ions for subsequent challenge with wear debris is a novel approach within 119 
this field and could developed into a viable cell culture model for analysis of the cellular 120 
effects of metal ions and particles. 121 
 122 
Methods 123 
 124 
Preparation of wear debris  125 
 126 
CoCr wear debris was donated by DePuy International (Leeds, UK). A high-carbon cast 127 
cobalt chrome hip resurfacing implant was worn on a multi-station hip joint simulator over 128 
250,000 cycles using distilled water as the lubricating fluid. The use of only distilled water 129 
(instead of the more usual bovine serum (25% (v/v) in distilled water) resulted in a more 130 
aggressive wear regime which produced a greater volume of wear debris of similar 131 
morphology and size to that produced under similar conditions in 25 per cent serum  (C. 132 
Hardaker, DePuy International Ltd, Leeds, UK, personal communication). The wear debris 133 
suspended in distilled water was centrifuged at 3,500g for 20min. The water was then 134 
aspirated and the debris was heat-treated (180°C for 5h, 60kPa) in a vacuum oven to destroy 135 
any endotoxin. The dry debris was suspended in sterile phosphate buffered saline (PBS; Life 136 
Technologies; Paisley, UK). Heat-treated wear debris was characterised with a Field 137 
Emission Scanning Electron Microscope (FE-SEM) (Hitachi SU-6600, Hitachi; Germany) at 138 
magnifications of 100-1000x. The sample was then transferred to a Scanning Electron 139 
Microscope (SEM) (Hitachi TM-1000, Hitachi; Germany). Energy Dispersive X-ray 140 
Spectroscopy (EDS) was used for quantitative analysis of elemental composition. Hitachi 141 
TM-1000 and EDSwift-TM software was used to obtain the images and chemical spectra of 142 
the wear debris.  The sterility of the treated wear debris was tested as described elsewhere 143 
(24) by exposing dendritic cells (isolated from bone marrow of male BALB/c (Harlan, UK) 144 
mouse femurs and tibias (25)) to the debris for 24h, in vitro, and assessing the expression of 145 
surface activation markers via flow cytometry. The debris was found not to increase the 146 
surface expression of CD40, CD86, or MHC II on these cells, and, therefore, the suspended 147 
debris was deemed sterile and endotoxin-free (data not shown). 148 
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Metal ion release into cell culture medium 149 
2.5mg metal wear debris/1x106cells were incubated for 24h in RPMI-1640 (pH 7.4) in the 150 
presence and absence of foetal calf serum (FCS, Life technologies; Paisley, UK) and in 151 
complete RPMI-1640 at pH 4. Every condition was carried out in triplicate and controls of 152 
each condition with no metal debris were also present. In addition to this, 0.2, 0.5, 1, 2.5 and 153 
5mg metal wear debris/1x106cells were incubated in complete RPMI-1640 for 24h at 37°C 154 
and 5% (v/v) CO2. Every concentration was carried out in triplicate and appropriate controls 155 
with no metal debris were also present. At 24h, culture medium from each well was collected 156 
into microcentrifuge tubes and stored at -80°C until ICP-MS analysis. 157 
 158 
Cell culture 159 
U937 [Human leukemic monocyte lymphoma cell line; European Collection of Cell Cultures] 160 
cells were cultured in RPMI-1640 medium supplemented with 10% (v/v) FCS, 50U/ml 161 
penicillin and 50µg/ml streptomycin. Co2+ solutions were freshly prepared using cobalt 162 
chloride (CoCl2) (Alfa Aesar; Lancashire, UK) and diluted to 0.1µM in growth medium 163 
under sterile conditions. In order to analyse ion up-take, resting cells were seeded at 164 
1x105cells/ml in 24-well plates and exposed to 0, 0.2, 0.5, 1, 2.5 and 5mg metal wear 165 
debris/1x106cells for 24h at 37°C and 5% (v/v) CO2. For cell viability assessment, cells were 166 
cultured (1x104cells/well) in 96-well plates with 5mg debris/1x106cells, 0.1µM of Co2+, or 167 
the combination of 5mg debris/1x106cells plus 0.1µM of Co2+ in complete RPMI-1640 for 24 168 
and 120h at 37°C under 5% (v/v) CO2. For apoptosis analysis, 1x105cells/ml U937 cells and 169 
U937 cells treated with 0.1µM Co for 72h, were exposed for 24 and 48h (to measure both 170 
early apoptosis and detect any repair) to 2.5mg metal wear debris /1x106cells, 0.1µM Co and 171 
2.5mg metal wear debris /1x106cells plus 0.1µM Co, in 12-well plates at 37°C and 5% (v/v) 172 
CO2. For gene expression analysis, U937 and Co pre-treated U937 cells were exposed to the 173 
same three treatments but for a period of 120h. This longer time point was chosen to reflect 174 
the chronic effects of exposure to wear debris and ions on gene expression in patients in vivo. 175 
 176 
ICP-MS analysis 177 
For the analysis of cellular ion up-take, cells were centrifuged at 350xg for 5min, and then 178 
washed twice with PBS. After the second wash, the PBS was discarded and cell pellets 179 
sonicated for 30min at 45°C. Cell lysates were then resuspended in 1ml of ultrapure water 180 
PȍDQGVWRUHGDW-20°C overnight. Thawed cell lysates and culture medium samples were 181 
centrifuged at 13,200rpm for 15min. Cell lysates were diluted 5-fold in 2% (v/v) HNO3 and 182 
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culture medium samples were diluted 10-fold in RPMI-1640. Standards were prepared by 183 
diluting Multi-element Standard Solution 1 for ICP (Fluka) in 2% (v/v) HNO3 (standards for 184 
cell lysates) or RPMI-1640 (standards for medium samples) for 1, 10, 50, 200, and 500µg/L 185 
Co final concentrations. All samples were analysed using an Agilent 7700x octopole collision 186 
system ICP-MS (Agilent Technologies; Wokingham, UK) in helium gas mode using 187 
Scandium as internal standard. The quantification was based on the maximum signal for a 188 
particular isotope, also referred to as peak height. Five readings were taken, and the result 189 
obtained was the mean value. 190 
 191 
Cell viability measured by MTT 192 
Culture plates were centrifuged at 350xg for 5min and supernatant aspirated. Cell pellets 193 
were suspended in 10mM 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 194 
(MTT; Sigma-Aldrich; Dorset, UK) solution (50µl) and then incubated for 4h at 37°C, under 195 
5% (v/v) CO2. Following incubation, culture plates were centrifuged (350xg, 5min) and 196 
VXSHUQDWDQWUHPRYHG&HOOVZHUHWKHQUHVXVSHQGHGLQȝORIGLPHWK\OVXOIR[LGH'062WR197 
dissolve the formazan product. Optical absorbance was measured at 540nm using a Bio-Rad 198 
Model 450 microplate reader (Bio-Rad, Hertfordshire, UK). 199 
 200 
Cell viability measured by NR 201 
Culture plates were centrifuged at 350xg for 5min and supernatant aspirated. Cell pellets 202 
were suspended in 0.2mM NR (Sigma-Aldrich; Dorset, UK) solution (100µl) and then 203 
incubated for 3h at 37°C, under 5% (v/v) CO2. Following incubation, culture plates were 204 
centrifuged at 350xg for 5min and washed once with 200µl of PBS. NR de-stain solution was 205 
prepared  by mixing together 50ml ethanol (Sigma-Aldrich; Dorset, UK), 1ml glacial acetic 206 
acid (Sigma-Aldrich; Dorset, UK) and 49ml distilled water. 100µl of this solution was added 207 
to each well and it was left for at least 30min on an orbital shaker until all of the pellets 208 
present had been dissolved and a homogeneous colour was obtained in each well. Optical 209 
absorbance was measured at 540nm using a Bio-Rad Model 450 microplate reader (Bio-Rad, 210 
Hertfordshire, UK). 211 
 212 
Flow cytometry analysis of apoptosis 213 
All buffers and stains for flow cytometry were obtained from BD Bioscience, Oxford, UK. At 214 
HDFK HQGSRLQW 8 FHOOV ZHUH FROOHFWHG E\ FHQWULIXJDWLRQ DQG ZDVKHG WZLFH ZLWK ȝO215 
fluorescence-activated cell sorting (FACS) buffer (1×PBS containing 2% (v/v) FCS and 216 
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0.05% (w/v) sodium azide). Cells were then resuspended in ȝOîDQQH[LQELQGLQJEXIIHU217 
DQG LQFXEDWHG IRU PLQ ZLWK DOLTXRWV ȝO RI phycoerythrin-labelled annexin V and 7-218 
DPLQRDFWLQRP\FLQ'LQ WKHGDUN7KHUHDIWHUȝORIîDQQH[LQELQGLQJEXIIHUDQG)$&6219 
flow were added to each tube and the samples analysed by a FACSCanto flow cytometer (BD 220 
Bioscience). A minimum of 20,000 events in the target area were recorded for each sample. 221 
All data were analysed using FACSDiva software (BD Biosciences). 222 
 223 
Western blot analysis of apoptosis 224 
Total protein content was measured by Lowry assay (26). Homogenates from both treated 225 
and untreated U937 cells were prepared in Laemmli buffer and 10µg of protein were 226 
separated on 10% SDS-polyacrylamide gels (SDS-PAGE). Samples were immunoblotted 227 
using a rabbit polyclonal antibody to Poly-ADP-Ribose-Polymerase (PARP, 1:2000, Roche; 228 
West Sussex, UK) and anti-rabbit IgG-ALP (1:1000, BioRad; Hertfordshire, UK). The 229 
optical densities of the protein bands were then quantified using Image J 1.42q software. 230 
 231 
RNA isolation and cDNA synthesis 232 
Total RNA from cell cultures was extracted using the GenElute Mammalian Total RNA 233 
Miniprep Kit (Sigma-Aldrich; Dorset, UK) as described by the manufacturer, including the 234 
on-column RNase-free DNase digestion. RNA yield and purity were quantified by 235 
spectrophotometric analysis with NanoDrop 2000c (Thermo Scientific; Washington, USA). 236 
RNA integrity was verified with an Experion automated electrophoresis system (Bio-Rad; 237 
+HUWIRUGVKLUH8.F'1$ZDVSUHSDUHGIURPȝJRIWRWDO51$XVLQJ6XSHUVFULSW-II reverse 238 
transcriptase (Invitrogen; Paisley, UK) and oligo(dT)24 (500ng/µl, Eurofins MWG Operon; 239 
London, UK). 240 
 241 
Quantitative Real-time PCR 242 
Oligonucleotide primers (Table 1) for the genes of interest were used in SYBR-Green based 243 
quantitative real-time reverse-transcription-3&5RQD6WHS2QH3OXV5HDO-Time PCR system 244 
(Applied Biosystems; Paisley, UK) with SYBR-Select Master Mix (Applied Biosystems; 245 
Paisley, UK). Primer sets were designed using the sequence analysis software, GeneRunner 246 
v3.05 (Hasting Software, USA) and Primer-BLAST (27) to produce an amplicon between 247 
100 and 150bp long and to ensure the primers spanned exons to minimise the risk of genomic 248 
DNA amplification. Triplicate real-time PCR reactions were run with each primer set for 249 
each sample DQGFRQWDLQHGȝO6<%5-Select Master Mix, 3µl of forward primer (1pmol/µl; 250 
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Eurofins MWG Operon; London, UK), 3µl of reverse primer (1pmol/µl, Eurofins MWG 251 
2SHURQ /RQGRQ 8. ȝO F'1$ QJO WHPSODWH DQG PROHFXODU-grade H2O (Sigma-252 
Aldrich; Dorset, 8.XS WR WKH WRWDO UHDFWLRQYROXPHRIȝO7KH IROORZLQJVWDQGDUG UHDO-253 
time PCR conditions were used: 1 cycle of 50°C for 2min; 1 cycle of 95°C for 2min; and 40 254 
cycles of 95°C for 15s followed by 60°C for 1min. Following amplification, a melting curve 255 
analysis was performed to ensure the PCRs generated the single predicted amplicon. The 256 
6WHS2QH3OXV VRIWZDUH Y DXWRPDWLFDOO\ VHW WKH EDVH OLQH DQG WKUHVKROG IRU HDFK257 
reaction. A quantification cycle (Cq) was assigned at the beginning of the logarithmic phase 258 
of PCR amplification and the difference in the Cq values of the control and experimental 259 
samples was used with the Comparative Cq method (28), to determine the relative expression 260 
of the gene in each sample. Template-negative controls were also run in order to test for 261 
genomic DNA contamination. Three genes (GAPDH, B2M, and HPRT1) were included as 262 
potential reference genes. After analysis of their expression stability under the treatment 263 
regimes using RefFinder (29) (data not shown), the gene HPRT1 was chosen as the reference 264 
gene and its expression used for normalization.  265 
 266 
Statistics 267 
Statistical analyses were carried out by a one-way analysis of variance, followed by a 268 
'XQQHWW¶VPXOWLSOHFRPSDULVRQWHVWDQGDWZR-sample t-test. Significance was assigned where 269 
p values were found to be <0.05. 270 
 271 
Results 272 
 273 
Characterisation of heat treated wear debris 274 
SEM images show irregular shapes and sizes varying from the nano to the micro scale (from 275 
150nm to 6.5µm). The larger irregular shaped particles suggest that the debris aggregates 276 
(Image 1), and this has been reported previously by Akbar and coworkers (24). EDS analysis 277 
indicated that the wear debris is primarily composed of Co and Cr, which is in agreement 278 
with the alloy composition (30). Analysis of 25 different particles indicated a mean 279 
composition of 59.57 per cent (± 1.15) Co and 40.43 (±1.25) per cent Cr, with a small content 280 
of Mo which was below the quantification limit.   281 
 282 
 283 
 284 
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Cell viability 285 
U937 and Co pre-treated U937 cell viability was assessed after 24 and 120h of treatment in 286 
terms of metabolic activity (MTT) and cell number (NR) (Table 2). After 24h, there was a 287 
general increase in cell metabolic activity (MTT) in response to all treatments. In contrast to 288 
this, NR showed a significant decrease in cell number for Co pre-treated cells exposed to 289 
wear debris and the combination of wear debris and Co ions when compared to control 290 
untreated U937 cells. After 120h, there was significant decrease in both cell number (NR) 291 
and metabolic activity (MTT) where the debris was present. In contrast to this, a significant 292 
increase in both cell number (NR) and metabolic activity (MTT) was observed in cells treated 293 
with Co ions alone. In addition to the above, the effects on U937 and Co pre-treated U937 294 
cells were compared in order to establish if the pre-treatment with Co ions made a difference 295 
to the effects caused by the exposure to metal debris and Co. At 24h, there was a significant 296 
difference caused by Co pre-treatment in the effect of 5mg debris/1x106cells in cell number. 297 
At 24h and 120h there was a significant difference caused by Co pre-treatment on the effects 298 
of combined 5mg debris/1x106cells and 0.1µM Co on cell number. These results suggest that 299 
chronic exposure to high concentrations of wear metal debris could have a detrimental effect 300 
on cell viability particularly if the cells have been previously exposed to Co ions. 301 
 302 
Metal ion release into cell culture medium 303 
Metal debris was incubated, in the absence of U937 cells, under different conditions in order 304 
to analyse the effects that some variables have on the amount of metal ions released into the 305 
culture medium. Analysis of ICP-MS results found that CoCr debris released metal ions into 306 
culture medium (Table 3). There was no significant difference (p>0.05) in ion release from 307 
metal debris in the presence and absence of 10% (v/v) FCS. This concentration of FCS was 308 
used as it was the concentration used when the CoCr wear debris was incubated with U937 309 
cells for up to 120h to determine effects on apoptosis and gene expression. In contrast to 310 
these data, the acidic pH 4.0 had a considerable effect as seen in the significant increase 311 
(p<0.05) in the levels of ion release. Such a low pH was chosen in order to mimic local 312 
acidification during inflammation (31) and the acidic lysosomal medium (32). Even though 313 
Co was the ion predominantly released in all cases, the change in pH seemed to have a more 314 
pronounced effect on Cr ion release. 315 
 316 
Increasing concentrations of metal debris were also incubated in order to analyse the 317 
correlation between debris concentration and metal ions released (Figure 1). Analysis of ICP-318 
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MS results found a significant (p<0.05) increase in the amount of ions released with 319 
increasing wear debris concentrations. However, the increase in ion release was not linear 320 
with respect to debris concentrations (Figure 1). Once again, Co was the ion detected at the 321 
highest concentrations.  322 
 323 
Metal ion up-take by U937 cells 324 
U937 cells were exposed to increasing metal debris concentrations in order to establish 325 
cellular up-take of ions released into the culture medium by CoCr wear debris. Analysis of 326 
ICP-MS results found significantly higher (p<0.05) up-take of Co than Cr for all treatments 327 
(Figure 2, Table 4). Molybdenum (Mo) up-take into the cells could not be detected. There 328 
was an increase in ion up-take with increasing wear debris concentrations, but the increase in 329 
ion up-take was not linear with respect to debris concentrations. Additionally, a slight 330 
decrease was observed in ion levels measured when cells were exposed to 5mg 331 
debris/1x106cells probably due to the fact that this concentration has been shown to be 332 
cytotoxic. Of special interest is the fact that the Cr and Co ion concentrations in Figure 2 and 333 
Table 4 are expressed as concentration per single cell. This indicates that a significant high 334 
amount of metal ions was being taken up by the cells, and this could be related to the adverse 335 
tissue response to metal wear debris and ions. After their intracellular accumulation particles 336 
are often stored in acidic lysosomal vacuoles where intracellular dissolution can occur (32). 337 
As shown in the section above, significant increase in ion release was observed at pH 4. The 338 
results herein suggest that the levels of intracellular metal ions measured could be due to 339 
either intracellular ion release through the actions of the low pH compartments of the 340 
lysosomal-endosomal compartment following particle endocytosis or a combination of both 341 
intracellular particle degradation and ion up-take from the extracellular culture medium. 342 
 343 
Apoptosis analysis 344 
Cell viability assays carried out showed that the 5mg debris/1x106cells concentration was 345 
highly cytotoxic, and because of this 2.5mg debris/1x106cells concentration was chosen for 346 
the analysis of apoptosis and gene expression. Although this is still a high dose, it was 347 
considerably less toxic and allowed detection of early apoptosis, and isolation of enough 348 
RNA for the gene expression assays. 349 
 350 
The results of examination of phosphatidylserine (PS) externalization and detection of the 351 
89kD PARP fragment consistently revealed that CoCr wear debris induced apoptosis in U937 352 
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cells. Flow cytometry using Annexin V/FITC and 7-AAD double staining revealed that after 353 
exposure to 2.5mg debris/1x106cells and 2.5mg debris/1x106cells with 0.1µM Co, the number 354 
of cells with externalized PS started to increase by 24h of treatment. This increase became 355 
significant by 48h of exposure (Figure 3). Metal debris induced a greater PS externalization 356 
in cells that had been pre-treated with Co, as seen by the increase from 10.2%±0.4 early 357 
apoptosis in non-Co pre-treated cells to 15.63%±0.63 early apoptosis in Co pre-treated cells. 358 
These results are in agreement with the cell viability results where an enhanced cytotoxic 359 
effect was observed in Co pre-treated cells, and thus suggest an important role of Co ions in 360 
the metal debris toxicity. 361 
 362 
Anti-PARP recognizes Poly-ADP-Ribose-Polymerase (PARP), a 113kD protein that binds 363 
specifically at DNA strand breaks (33). PARP is also a substrate for certain caspases (for 364 
example, caspase 3 and 7) activated during early stages of apoptosis (34). These proteases 365 
cleave PARP to fragments of approximately 89kD and 24kD and detection of one or both 366 
fragments has been used as a hallmark of apoptosis (35). Western blot analysis validated the 367 
flow cytometry results by showing the fragmentation of PARP after 48h of exposure to 368 
2.5mg debris/1x106cells and 2.5mg debris/1x106cells with 0.1µM Co (Figure 4), which was 369 
not seen at the 24h time point. The histograms of mean optical densities for full length PARP 370 
(Figure 5), showed a significant increase, compared to controls, in the amount of PARP 371 
detected for Co pre-treated cells treated with the combination of metal debris and Co ions for 372 
24h. Furthermore, after 48h of treatment, there was a significant decrease, compared to 373 
controls, in the amount of full length PARP detected for cells incubated in the presence of 374 
metal debris. Such a decrease in full length PARP corresponds to the fragmentation of the 375 
protein, as detected in the gels by the presence of the cleaved 89kD band, and is indicative of 376 
apoptosis. 377 
 378 
Gene expression analysis 379 
The StellARrayTM Gene Expression System (Lonza; Switzerland) is a quantitative 380 
polymerase chain reaction (qPCR)-based method and provides profiling of biologically 381 
focused gene sets. Gene expression array analysis with the standard Human General 382 
Toxicology 96 StellARrayTM was performed in order to identify genes related to the toxic 383 
effects of metal wear debris and ions on U937 cells. Cells were exposed to the combination 384 
of 2.5mg/1x106cells wear debris and 0.1µM Co for 120h. Untreated resting U937 cells were 385 
used as control (data not shown). Based on the results from this assay, the genes lymphotoxin 386 
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alpha (LTA), BCL2-associated athanogene (BAG1), growth arrest and DNA-damage-387 
inducible alpha (GADD45A), inducible nitric oxide synthase (NOS2) and FBJ murine 388 
osteosarcoma viral oncogene homolog (FOS) were selected to be analysed in the context of 389 
prosthetic wear debris. Additionally, the StellARray gene set was submitted to Toppgene (36) 390 
for analysis and the chosen genes were found to be involved in at least one of the following 391 
biological processes: regulation of cell death, regulation of programmed cell death, response 392 
to toxin, negative regulation of growth, response to metal ions, regulation of cell 393 
proliferation, nitric oxide metabolic process, and oxygen and reactive oxygen species 394 
metabolic process. 395 
 396 
To address the effect of wear particles, the mRNA expression of general human toxicology-397 
related genes NOS2, LTA, BAG1, GADD45A, and FOS was studied 120h after treatment 398 
with 2.5mg debris/1x106cells, 0.1µM Co and 2.5mg debris/1x106cells plus 0.1µM Co (Table 399 
5) The 120h time point was chosen to investigate the longer term effects on gene expression 400 
taking into consideration prolonged exposure to the debris in patients in vivo. BAG1 and 401 
NOS2 were affected by all the treatments. BAG1 expression significantly increased in cells 402 
under all treatments but was higher in the presence of Co. Expression of NOS2 decreased in 403 
the presence of metal particles but the opposite effect was observed in the presence of Co. 404 
FOS expression increased in the presence of metal debris. LTA and GADD45A were the 405 
genes less affected. Expression of LTA increased significantly in the presence of both debris 406 
and Co when cells were pre-treated with Co. Although GADD45A expression increased in 407 
cells exposed to debris, a larger effect was observed when Co pre-treated cells were exposed 408 
to both debris and Co. In general, pre-treatment with Co resulted in bigger fold changes.  409 
 410 
Discussion 411 
 412 
The progressive loss of bone adjacent to an implant has been attributed to a granulomatous 413 
inflammatory reaction induced by particulate implant wear debris at the bone±implant 414 
interface (37). Degradation products of metallic biomaterials include particulate wear debris, 415 
free metallic ions and inorganic metal salts or oxides (5). These are released into surrounding 416 
tissue by various mechanisms, including corrosion, wear, and mechanically accelerated 417 
electrochemical processes such as stress corrosion, corrosion fatigue, and fretting corrosion 418 
(38).  419 
 420 
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Corrosion is a natural phenomenon where higher energy states of a metal attain equilibrium 421 
by transforming to such constituents as natural ore, which have lower energy states (39). All 422 
metals in contact with a biological system undergo corrosion through an electrochemical 423 
redox reaction and an oxide layer is quickly formed on the surface of a metallic implant (40). 424 
When CoCr alloy is in contact with body fluids, cobalt is completely dissolved, and the 425 
surface oxide changes into chromium oxide containing a small amount of molybdenum oxide 426 
(41). It has been reported that local acidification may develop during acute and chronic 427 
inflammation (31). In turn, such an acidic environment, created by actively metabolizing 428 
immune cells, may enhance the corrosion process, and disrupt the surface oxide film leading 429 
to a significant increase in ions released (40). In this study, ICP-MS analysis showed 430 
significantly higher concentrations of Co and Cr when incubating wear debris at low pH. 431 
These findings suggest that the osteolysis process generated by wear debris may be 432 
exacerbated by the lowering of pH at the inflammation site, which would be in line with 433 
reports of synovial-fluid acidosis correlating with radiological joint destruction in 434 
rheumatoid-arthritis knee joints (42). Moreover, increasing ion concentrations were measured 435 
in culture medium with increasing amounts of wear debris. Results showed higher 436 
concentrations of Co than Cr, which could be explained partly by the alloy composition (62±437 
67% Co, 27±30% Cr, 5±7 % Mo,  and ~1% Ni (30)) but also by the fact that cobalt is 438 
preferentially released from CoCr alloy during the corrosion process (41). These observations 439 
seem to also be in accordance with the study carried out by Hart et al. (2012) (43). They 440 
examined periprosthetic tissue from patients with MoM hip implants and their results suggest 441 
that the amount of Co rather than its speciation is the reason for a higher failure rate. Caicedo 442 
et al. (2013) found that irregularly shaped particles have a greater surface area compared to 443 
the smooth surface of round particles and thus demonstrated a greater release of metal ions 444 
(44).  In this study, SEM characterisation of the heat treated debris showed irregularly shaped 445 
particles which could have contributed to the ion release.  446 
 447 
Molecular details of cobalt uptake are not well known and whether Co enters mammalian 448 
cells via a specific transporter is not known either (45, 46). However, it is likely that it is 449 
transported into the cells by broad-specificity divalent metal transporters (45). It has been 450 
shown that P2X7, a transmembrane ionotropic receptor, is involved in the uptake of divalent 451 
cations and Co (47). In the same way, a protein named divalent metal transporter 1 (DMT1) 452 
has been shown to have a broad substrate specificity favouring divalent metals including Co2+ 453 
(48). Additionally, it has been suggested that the cellular uptake of Co was mediated by 454 
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active transport ion pumps (i.e. Ca2+/Mg2+ ATPase and the Na+/K+ ATPase) and endocytosis 455 
(49). The only biological known function of cobalt is its integral part of vitamin B12, which 456 
is incorporated into enzymes that participate in reactions essential to DNA synthesis, fatty 457 
acid synthesis and energy production (45, 46). Even though cobalt has a role in biological 458 
systems, overexposure results in toxicity due to excess (45), which promotes the development 459 
of hypoxia and increases in the level of reactive oxygen species (ROS), suppresses synthesis 460 
of ATP, initiates apoptotic and necrotic cell death (50). Cobalt ions can directly induce DNA 461 
damage, interfere with DNA repair, DNA±protein crosslinking and sister chromatid exchange 462 
(51). The exact mechanism for cobalt carcinogenicity remains to be elucidated but it has been 463 
established that cobalt-mediated free radical generation contributes to the toxicity and 464 
carcinogenicity of cobalt (52). At  low doses below the no-observed-adverse-effect level 465 
(NOAEL), previous investigators have documented evidence that some nanoparticles can 466 
initiate hormesis (53). Hormesis is a dose-response relationship characterized by a low-dose 467 
stimulation and a high-dose inhibition. In the current study, the effects observed in viability 468 
could be related to such phenomenon. The 0.1µM Co concentration used in this study is very 469 
low compared to the concentrations of ions being released into the culture medium by the 470 
debris. Thus, it is possible that low concentrations of Co ions may exert an adaptive response 471 
leading to hormesis. 472 
 473 
It has been shown that cell membranes are relatively impermeable to Cr3+ and the cellular 474 
uptake of Cr6+ is several fold greater than that of Cr3+ ion (54). In contrast to Cr3+, Cr6+ is 475 
rapidly taken up by erythrocytes after absorption and reduced to Cr3+ inside the cell. Cr6+ 476 
enters the cell through non-specific anionic channels, such as the phosphate and sulphate 477 
anion exchange pathway (55). Once within the cell, Cr6+ is reduced metabolically by redox 478 
systems to the short-lived intermediates Cr5+ and Cr4+, and ultimately to the most stable 479 
species, Cr3+ (56). Cr3+ interacts and forms complexes with DNA, protein and lipids resulting 480 
in increased chromium intracellular levels (55). This would also explain the higher cellular 481 
up-take of metal ions at higher debris concentrations. Cellular Co and Cr up-take results are 482 
also in agreement with previous reports of Co2+ having a higher capacity, in the context of 483 
implants, to penetrate cells than Cr3+ (57). Using microfocus X-ray spectroscopy, Hart et al. 484 
found that Co in peri-implant tissues is complexed to an organic molecule whereas Cr forms 485 
an inorganic complex with phosphate (43). Based on these findings they postulated that the 486 
materials released from the implants are not predominantly resident in the tissues as alloy 487 
particles, but as dissolved constituents of alloy particles. Furthermore, the lysosome is the 488 
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most common intracellular compartment for particles sequestration and degradation. The role 489 
of lysosomes in particles intracellular dissolution has been shown in the case of carcinogenic 490 
nickel particulate compounds (58), zinc oxide nanoparticles (59), and iron oxide 491 
microparticles (60). In this context, intracellular particle solubilisation may also contribute to 492 
the ion levels measured in this study, and could be in part responsible for the toxicity 493 
observed. 494 
 495 
Several investigations about the effects of different kinds of metals, particles, and ions on 496 
human monocytes and macrophages have been published. Dalal et al. (61) compared the 497 
responses of human osteoblasts, fibroblasts, and macrophages exposed to particles of 498 
different metal-based particles (i.e., cobalt-chromium (CoCr) alloy, titanium (Ti) alloy, 499 
zirconium (Zr) oxide, and Zr alloy). They found that CoCr-alloy particles were by far the 500 
most toxic and decreased viability and proliferation of human osteoblasts, fibroblasts, and 501 
macrophages. Potnis et al. (62) challenged monocytes (THP-1) with Co-alloy particles and 502 
demonstrated that these particles trigger an immune response via the TLR4-MyD88-503 
dependent pathway. Caicedo et al. (44) also challenged THP-1 cells with CoCr nanoparticles. 504 
They showed that as metal particles decrease in size, the greater the contribution of metal 505 
ions to the overall induction of IL-ȕPHGLDWHGUHVSRQVHVThe release of corrosion products 506 
from implanted metals, mainly chromium, cobalt, nickel and titanium, has been associated 507 
with clinical complications such as adverse tissue reactions, promotion of infection and metal 508 
sensitivity in vivo as well as apoptosis and necrosis in vitro. (63). In the present study, 509 
apoptosis was detectable after 24h of exposure to wear debris, and wear debris combined 510 
with Co ions, and became significant after 48h as seen in both FACS and western blot 511 
analysis. Co ions on their own did not induce apoptosis probably due to low concentration 512 
(0.1µM Co). The apoptotic effects of Co ions have mainly been reported at concentrations 513 
starting from 100µM, where Co induced cell death in a dose and time dependent manner (64). 514 
Results reported herein support these observations. This suggests that the increase in ion 515 
release in vivo at an acidic peri-implant environment would enhance cell death and intensify 516 
the immune reaction. Several cellular components functioning in apoptosis have been 517 
reported. Among them, Bcl-2 is known to suppress multiple forms of apoptosis (65). It has 518 
been shown that co-expression of BAG1 (Bcl-2 association athagogene 1) and Bcl-2 519 
increases protection from cell death (66). BAG1 is a multifunctional and anti-apoptotic 520 
protein that enhances the anti-apoptotic function of Bcl-2 (67). In the present study, up-521 
regulation of BAG1 was observed in treated U937 cells compared to controls, which suggests 522 
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the cells were under apoptotic stimuli. This, in turn, suggests that BAG1 could be part of a 523 
defence mechanism for delaying cell death in response to metal toxicity, particularly Co 524 
toxicity in this case. Considering that the up-regulation was predominantly observed in the 525 
presence of Co ions treatment compared to the debris alone, cobalt could be considered a 526 
potent apoptotic inducer. The clear identification of PARP fragments at 48h complements the 527 
FACS results, which show the role of metal ions and debris as inducers of apoptosis 528 
particularly in cells that have been pre-exposed to Co2+. This could have great significance 529 
for patients with failed MoM articulations undergoing revision surgery. It has been reported 530 
that at greater than one year post-removal of a large diameter MoM hip implant for the 531 
indication of symptomatic metallosis, metal ion levels in whole blood fall to almost normal 532 
levels (68). Similarly, it has been shown that serum levels of Co and Cr decrease after MoM 533 
articulation revision surgery (69). Whole blood Co and Cr ion levels before revision surgery 534 
RIȝJODQGȝJOUHVSHFWLYHO\DQGDIWHUUHYLVLRQVXUJHU\RIJODQGJO535 
respectively, have been reported (68). Similarly, average serum Co and Cr ion levels before 536 
UHYLVLRQVXUJHU\RIȝJODQGȝJOUHVSHFWLYHO\DQGDIWHUUHYLVLRQVXUJHU\RIȝJO537 
DQGȝJOUHVSHFWLYHO\KDYHDOVREHHQUHSRUWHG(70). The 9th National Joint Registry for 538 
England and Wales reported a total of 80,314 hip procedures performed in 2011, an increase 539 
of 5% over 2010. Of these, 8641 were revision procedures and 466 were bilateral. However, 540 
the number of patients with bilateral hip replacements is likely to be greatly underestimated 541 
since bilateral procedures are only counted as a bilateral if they are entered under the same 542 
operation during data entry. If the two procedures are recorded under two different operations 543 
they will be counted as two unilateral procedures (71). Results from this study suggest that if 544 
a second (either bilateral or revision) CoCr implant were implanted it may be more likely to 545 
produce adverse effects than the first one. 546 
 547 
The acidic environment of inflammatory lesions is due to increased metabolic acid generation 548 
during cell activation (72). In most cases, acidosis occurs along with nitric oxide (NO) 549 
generation. In inflammatory processes, macrophages release cytokines that cause the 550 
expression of NOS2, responsible for high output production of NO for extended time periods 551 
(72). NO has been proposed to exhibit a pro-inflammatory action by enhancing NF-ț%552 
activation in response to inflammatory agents (23). qRT-PCR results analysis showed 553 
significant up-regulation of NOS2 in cells exposed to Co ions or the combination of Co ions 554 
and debris, especially in cells pre-treated with Co. Since the induction of NOS2 is 555 
characteristic of activated macrophages, these findings suggest that metal debris and ions 556 
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have the potential to activate resting macrophages. Moreover, such over-expression of NOS2 557 
could have a predominant role in the inflammation and acidification of the peri-implant 558 
microenvironment discussed above. Additionally, NO acts in a paracrine fashion and in 559 
macrophages activates the cyclooxygenase enzyme resulting in PGE2 release. PGE2 is 560 
capable of stimulating bone resorption and is recognized as a key inflammatory mediator in 561 
wear debris±mediated peri-prosthetic bone loss (73).  562 
 563 
Possible adverse health effects caused by accumulated metal particles in the periprosthetic 564 
tissues include osteolysis (74), inflammation, pain, and pseudotumours (75). Case et al. (76) 565 
reported that the accumulation of metal particles in lymph nodes cause structural changes 566 
such as necrosis and slight fibrosis. Additionally, there are case reports which suggest neuro- 567 
and cardio- toxicity from disseminated metal debris (15).   Multiple reports (15, 16, 77-82) 568 
have described patients with MoM implants who presented systemic symptoms including 569 
neurological symptoms such as auditory impairment/deafness, visual impairment/blindness, 570 
peripheral neuropathy/dysesthesia of the extremities, poor concentration/cognitive decline, 571 
cardiomyopathy and hypothyroidism. All patients had elevated cobalt and/or chromium 572 
concentrations in their blood, serum, plasma, and/or urine, suggesting that these systemic 573 
symptoms may be due to metal toxicity as a result of excessive implant wear. Consistent with 574 
this notion, revision surgery to remove the defective metal hip prostheses resulted in lowered 575 
blood concentrations of metal ions and improved symptoms.  Thus, it seems reasonable to 576 
think that systemic elevated concentrations of Co ions, due to the presence of wear debris, 577 
pose a health risk for patients bearing CoCr MoM implants. 578 
 579 
Willert et al. (8) studied a group of patients who had a total MoM hip replacement   and had  580 
early recurrence of preoperative symptoms. After revision surgery to resolve these, hip and 581 
thigh pain persisted in the patients who had received a second MoM articulation, but was 582 
alleviated where patients received revision to either a ceramic-on-polyethylene or metal-on-583 
polyethylene bearings.  The authors suggested that an immunological response persisted after 584 
the first revision and that the patients had been sensitized to the components of the all-metal 585 
articulation. The current study has found that CoCr wear metal debris may be more toxic in 586 
the presence of Co ion pre-treatment. It would be of interest to investigate the biological 587 
responses to metal wear debris of primary cells isolated from revision surgery patients at 588 
different follow-up periods. Results from this investigation also suggested that ions released 589 
from wear metal debris play an important role in the cellular response at the peri-implant 590 
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tissues. In particular, they suggested that the toxicity of Co ions could be related to nitric 591 
oxide metabolic processes and apoptosis. In conclusion, this study showed that CoCr wear 592 
debris could be more effective as an inducer of apoptosis and gene expression when cells had 593 
been pre-treated with Co ions. Results from this approach suggest that if a patient receives a 594 
second CoCr implant (revision of a MoM or a bilateral implant) it may be more likely to 595 
produce adverse effects than the first one. Consequently, this could potentially be partly 596 
responsible for the results from revision surgery being regarded as inferior to primary hip 597 
arthoplasty in terms of both function and survival (83). Priming cells with Co ions for 598 
subsequent challenge with wear debris is a novel approach within this field and could be 599 
implemented as a cell culture model for analysis of the cellular effects of metal ions and 600 
particles. 601 
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Figure, Image and table captions 887 
 888 
Image 1. Scanning Electron Microscopy images of simulator generated wear debris 889 
from an ASR hip implant. Images taken at B) 50kX and D) 5kX with a FE-SEM Hitachi 890 
SU-6600.  891 
 892 
Figure 1. Metal ions in RPMI-1640 medium released from different concentrations of 893 
wear metal debris (per million cells) incubated with U937 cells for 24h. (a) Cr ion levels. 894 
(b) Co ion levels. (c) Mo ion levels. Results are expressed as mean values (±SEM, n=6). N.B. 895 
difference in y-axes. All values are significantly different from control (0mg 896 
debris/1x106cells) values (p<0.05) by one-ZD\ $129$ IROORZHG E\ 'XQQHWW¶V PXOWLSOH897 
comparison test. 898 
 899 
Figure 2. Cellular ion up-take after 24h exposure to different concentrations of wear 900 
metal debris. Results are expressed as mean values (±SEM, n=6). All values are significantly 901 
different from control (0mg debris /1x106cells) values (p<0.05) by one-way ANOVA 902 
IROORZHGE\'XQQHWW¶VPXOWLSOHFRPSDULVRQWHVW 903 
 904 
Figure 3. Early and late apoptosis of resting and Co pre-treated resting U937 cells 905 
exposed to  2.5mg debris/1x106cells, 0.1µM Co and a combination of 2.5mg 906 
debris/1x106cells and 0.1µM Co, measured by FACS. (a) Early apoptosis after 24h of 907 
treatment. (b) Late apoptosis after 24h of treatment. (c) Early apoptosis after 48h of 908 
treatment. (d) Late apoptosis after 48h of treatment. Results are mean values (±SEM, n=6). 909 
*Significantly different from control values (p<0.05) by one-way ANOVA followed by 910 
'XQQHWW¶VPXOWLSOHFRPSDULVRQWest. Significant difference between non-Co pre-treated cell 911 
and Co pre-treated cell values (p<0.05) by Two-sample t-Test. 912 
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 913 
Figure 4. Western blot analysis of extracts from U937 and Co pre-treated U937 cells 914 
showing PARP cleavage as evidence of induction of apoptosis. (a) Full length (113kD) 915 
PARP after 24h of treatment. (b) Full length (113kD) and cleaved (89kD) PARP after 48h of 916 
treatment. Cells were exposed for 24 and 48h to 2.5mg debris/1x106cells, 0.1µM Co and a 917 
combination of 2.5mg debris/1x106cells and 0.1µM Co. Lanes: 1. Molecular weight marker, 918 
2. Control, 3. U937+2.5mg, 4. U937+0.1µM Co, 5. U937+2.5mg+0.1µM Co, 6. Co pre-919 
treated U937+2.5mg, 7. Co pre-treated U937+0.1µM Co, 8. Co pre-treated 920 
U937+2.5mg+0.1µM Co.    921 
 922 
Figure 5. Optical densities of full length (113kD) PARP bands in western blot gels of 923 
extracts from U937 and Co pre-treated U937 cells exposed to 2.5mg debris/1x106cells, 924 
0.1µM Co and a combination of 2.5mg debris/1x106cells and 0.1µM Co. (a) Full length 925 
PARP after 24h of treatment. (b) Full length PARP after 48h of treatment. Results are mean 926 
values (± SEM, n=3). *Significantly different from control values (p<0.05) by one-way 927 
$129$ IROORZHG E\ 'XQQHWW¶V PXOWLSOH FRPSDULVRQ WHVW Significant difference between 928 
non-Co pre-treated cell and Co pre-treated cell values (p<0.05) by Two-sample t-Test.  929 
 930 
Table 1. PCR Primers used for qRT-PCR gene expression analysis. Table contains the 931 
gene symbol, GenBank accession number, primer sequence, melting temperatures (Tm) and 932 
predicted amplicon size for the primer sets used in this study. 933 
 934 
Table 2. Cell viability at 24 and 120h measured by Neutral Red and MTT. Results are 935 
percentage values (Mean ± SEM, n=9) where 100% corresponds to control values 936 
(Absorbance values 24h MTT:0.323 , NR:0.256 ; 48h MTT:0.686 , NR:0.317 ; 120h 937 
MTT:1.019, NR:0.467). *Significantly different from control values (p<0.05) by one-way 938 
$129$ IROORZHG E\ 'XQQHWW¶V PXOWLSOH FRPSDULVRQ WHVW 6LJQLILFDQW GLIIHUHQFH EHWZHHQ939 
non-Co pre-treated cell and Co pre-treated cell values (p<0.05) by Two-sample t-Test. 940 
 941 
Table 3. Metal ions in RPMI-1640 in the presence and absence of metal wear debris and 942 
no cells. Results are expressed as mean values (±SEM, n=3). *Significantly different control 943 
values (p<0.05) by one-ZD\ $129$ IROORZHG E\ 'XQQHWW¶V PXOWLSOH FRPSDULVRQ WHVW944 
6LJQLILFDQWGLIIHUHQFHEHWZHHQS+DQGS+ 945 
  
27 
 
 946 
Table 4. Cellular ion up-take after 24h exposure to different concentrations of wear 947 
metal debris. Results are expressed as mean values (±SEM, n=3). All values are significantly 948 
different from control (0mg debris /1x106cells) values (p<0.05) by one-way ANOVA 949 
IROORZHGE\'XQQHWW¶VPXOWLSOHFRPSDULVRQWHVW 950 
 951 
Table 5. Fold variations of mRNA expression of U937 cells treated with 2.5mg 952 
debris/1x106cells, 0.1µM Co and 2.5mg debris/1x106cells plus 0.1µM Co. mRNA was 953 
analysed by real-time RT-PCR. Untreated cells were used as control. Results are normalized 954 
to HPRT1 and given as fold increase of the mRNA levels in treated cells versus controls (1). 955 
Fold variation values are given as mean ± SEM of triplicates. All values significantly 956 
increased compared to control cells (p < 0.05) unless otherwise noted (ns, not significant). 957 
*Significantly lower than in control cells (p < 0.05). 958 
  959 
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Gene 3ULPHUVHTXHQFHV¶-> ¶QXFOHRWLGHV Tm Amplicon 
size (bp) 
NOS2 
NM_000625 
Sense GTGCAAACCTTCAAGGCAGCCT (22) 59.3 
127 Anti-
sense 
TGAGTCCTGCACGAGCCTGTAGTG (24) 60.3 
LTA 
NM_001159740 
Sense TGCTGCTCACCTCATTGGAGACC (23) 60.1 
123 Anti-
sense 
CTGGTGGGGACCAGGAGAGAATT (23) 59.2 
BAG1 
NM_004323 
Sense  TGCCCAAGGATTTGCAAGCTG (21) 59.7 
113 Anti-
sense  
TTCTGGCAGGATCAGTGTGTCAATC (25) 59.9 
GADD45A 
NM_001924 
Sense AACATCCTGCGCGTCAGCAAC (21) 59.7 
137 Anti-
sense  
AGATGAATGTGGATTCGTCACCAGC (25) 60.1 
FOS 
NM_005252 
Sense  ACGCAGACTACGAGGCGTCATCC (23) 61.3 
142 Anti-
sense 
GCCAGGTCCGTGCAGAAGTCC (21) 60.4 
B2M 
NM_004048 
Sense AGATGAGTATGCCTGCCGTGTGAAC (25) 60.3 
110 Anti-
sense 
CAAATGCGGCATCTTCAAACCTC (23) 59.5 
HPRT1 
NM_000194 
Sense  CCCTGGCGTCGTGATTAGTGATG (23) 60.2 
138 Anti-
sense 
CGAGCAAGACGTTCAGTCCTGTCC (24) 60.9 
GAPDH 
NM_002046 
Sense AGCCTCCCGCTTCGCTCTC (20) 58.2 
125 Anti-
sense 
ACCAAATCCGTTGACTCCGACC (23) 58.7 
Table 1  
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Cell Viability 24h 
 
Neutral Red 
Treatments 
Cells 5mg debris/1x106cells 0.1µM of Co2+ 5mg debris/1x10
6cells + 
0.1µM of Co2+ 
No Co pre-treatment 99.00±7.76 96.40±10.37 79.84±3.01 
 Co pre-treated 77.46±4.72 81.53±6.67 72.04*±3.12 
MTT 
Treatments 
Cells 5mg debris/1x106cells 0.1µM of Co2+ 5mg debris/1x10
6cells + 
0.1µM of Co2+ 
No Co pre-treatment 125.21±11.97 161.39*±13.71 161.26*±7.06 
 Co pre-treated 144.63*±6.06 146.28*±11.35 117.15±6.21 
Cell Viability 48h 
 
Neutral Red 
Treatments 
Cells 5mg debris/1x106cells 0.1µM of Co2+ 5mg debris/1x10
6cells + 
0.1µM of Co2+ 
No Co pre-treatment 79.01*±6.72 89.72±3.81 71.51*±5.58 
 Co pre-treated 67.57*±2.46 88.78±3.18 63.53*±1.11 
MTT 
Treatments 
Cells 5mg debris/1x106cells 0.1µM of Co2+ 5mg debris/1x10
6cells + 
0.1µM of Co2+ 
No Co pre-treatment 65.72*±3.48 117.98±7.65 77.84*±6.21  
 Co pre-treated 56.65*±3.73 98.49±4.72 72.19*±3.67 
Cell Viability 120h 
 
Neutral Red 
Treatments 
Cells 5mg debris/1x106cells 0.1µM of Co2+ 5mg debris/1x10
6cells + 
0.1µM of Co2+ 
No Co pre-treatment 34.68*±4.57 121.12*±5.44 57.47*±4.50 
 Co pre-treated 30.42*±2.59 100.12±9.85 31.84±4.68 
MTT 
Treatments 
Cells 5mg debris/1x106cells 0.1µM of Co2+ 5mg debris/1x10
6cells + 
0.1µM of Co2+ 
No Co pre-treatment 22.11*±7.78 129.70*±8.70 27.83*±6.84 
 Co pre-treated 11.74*±1.96 111.74±12.92 14.61*±1.57 
Table 2  
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Condition 
Mean Concentration [ µg/l ] ± SEM 
Cr Co Mo 
RPMI ± FCS (control) 0.15±0.12 0.03±0.03 3.17±0.33 
RPMI - FCS + Co-Cr wear debris  15.91*±1.65 1226.56*±38.97 127.82*±4.28 
RPMI + 10% FCS (control) 0.19±0.06 0.09±0.09 6.32±0.16 
RPMI + 10% FCS + Co-Cr wear debris 18.18*±2.64 1259.41*±39.58 124.60*±2.70 
pH4 RPMI + 10% FCS + Co-Cr wear debris 372.10±14.45 3182.85±115.68 222.26±7.69 
Table 3 
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Debris 
concentrations 
per 1x106cells 
Cr (fg/cell) 
Mean± SEM 
Co (fg/cell) 
Mean± SEM 
0.2mg  3.18±1.27 10.18±0.64 
0.5mg 5.09±0.64 24.17±1.27 
1mg 3.75±0.06 32.44±1.10 
2.5mg 16.54±0.64 122.14±2.92 
5mg 14.63±0.64 110.05±3.18 
Table 4  
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Cells Treatment 
Fold Change 
NOS2 LTA BAG1 GADD45A FOS 
U937  
2.5mg 
debris/1x106cells 0.36±0.03* 1.06±0.03 (ns) 2.19±0.14 1.16±0.50 2.55±0.07 
0.1µMCo 66.56±4.81 0.50±0.08(ns) 8.87±0.71 0.34±0.17(ns) 0.73±0.04(ns) 
2.5mg 
debris/1x106cells 
+0.1µMCo 
75.25±26.80 0.78±0.32(ns) 22.09±4.07 0.19±0.04(ns) 1.68±0.19 
Co 
pre-
treated 
U937 
2.5mg 
debris/1x106cells 0.38±0.07* 0.93±0.08(ns) 3.25±0.20 0.24±0.11(ns) 2.07±0.20 
0.1µMCo 275.89±40.51 0.73±0.09(ns) 11.56±0.39 0.57±0.19(ns) 0.82±0.12(ns) 
2.5mg 
debris/1x106cells 
+0.1µMCo 
423.38±10.83 2.75±0.13 9.08±0.73 11.45±1.24 2.94±0.26 
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Image 1 
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Figure 2  
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Figure 3  
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Figure 4  
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Figure 5 
